Could stroke patients skip the hospital? new trial tests Home-Based care for seniors

NCT ID NCT07420374

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new ambulatory (same-day) stroke care model to standard hospital care for patients aged 60 and older who have had a mild stroke or transient ischemic attack (TIA). Participants receive a full neurological assessment and treatment plan on the same day and then go home, while the control group stays in the hospital. The goal is to see if the home-based approach is just as good at helping patients recover without major complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ambulatory stroke unit care model (same-day assessment and discharge home)
What this could lead to
If successful, this could offer a safe, cost-effective alternative to hospital stays for elderly patients with mild stroke or TIA, freeing up hospital beds and reducing healthcare costs.
What could go wrong
This is an early exploratory trial, so results may not confirm non-inferiority. The ambulatory model may not be suitable for all patients, and there is a risk of delayed treatment for complications that would be caught in hospital.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Heidelberg University Hospital

    RECRUITING

    Heidelberg, 69120, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.